Risk Profile Assessment to Aid in Patient Selection Criteria for a Novel Lung Tissue Excision Tool in Lung Cancer Diagnosis and Intervention |
Lance Black |
Prana Thoracic |
NLST |
Oct 19, 2023 |
NLST-1142 |
Towards Explainable Deep Learning Model for Lung Nodule Diagnosis |
Chenglong Wang |
East China Normal University |
NLST |
Oct 19, 2023 |
NLST-1141 |
Adherence to a Low-carbohydrate Dietary Pattern Reduces Biliary Cancer Risk: Evidence from the PLCO Trial |
Rong Wang |
Zhongshan City People's Hospital |
PLCO |
Oct 17, 2023 |
PLCO-1357 |
Genomic Discovery: Therapeutic Targets for Non-Cancer Conditions |
Mary Black |
Foresite Labs |
PLCO |
Oct 16, 2023 |
PLCO-1356 |
Associations of BMI trajectories, weight gain, and the risk of pancreatic, biliary, liver and upper gi cancers |
Haiyang Peng |
Second Hospital Affiliated to Chongqing Medical University |
PLCO |
Oct 16, 2023 |
PLCO-1355 |
Identification and prediction of risk factors for upper gastrointestinal cancer |
bo zhu |
China Medical University |
PLCO |
Oct 16, 2023 |
PLCO-1350 |
Advancing Equity in Lung Cancer Screening Referrals: A Focus on Asian, Native, Alaskan, Hawaiian, and Pacific Islander Communities |
Amanda McCoy |
Lincoln Memorial University Debusk College of Osteopathic Medicine |
NLST |
Oct 10, 2023 |
NLST-1136 |
HANSE POST |
Jens Vogel-Clausen |
Hannover Medical School |
NLST |
Oct 10, 2023 |
NLST-1135 |
Development of lung cancer risk scores for determination of risk adapted screening intervals |
Rudolf Kaaks |
German Cancer Research Center (DKFZ) |
NLST |
Oct 10, 2023 |
NLST-1134 |
Comprehensive analyses of Fat Quality Index and incidence and mortality of lung cancer: A prospective cohort study |
Linglong Peng |
The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. |
PLCO |
Oct 10, 2023 |
PLCO-1353 |
Investigation into the Effect of Dimensionality Reduction Techniques on Machine Learning Algorithm. |
Oluwaseun Ifekoya |
University of Hull |
PLCO |
Oct 5, 2023 |
PLCO-1349 |
Evolution of cancer stage and mortality in the PLCO trial |
Robert Schoen |
U. of Pittsburgh |
PLCO |
Oct 4, 2023 |
PLCO-1346 |
Addressing equity in lung cancer early detection through identification of high risk clinical and radiographic features in minority and disadvantaged patients. |
Ameen Salahudeen |
The Board of Trustees of the University of Illinois on behalf of The University of Illinois at Chicago. |
NLST |
Oct 3, 2023 |
NLST-1125 |
Development and validation of prognostic models of lung cancer following low-dose computed tomographic screening |
Fergus Imrie |
University of Cambridge |
NLST |
Oct 3, 2023 |
NLST-1132 |
Lung Cancer Research |
Md. Sultan Moheuddin |
East West University |
NLST |
Oct 3, 2023 |
NLST-1131 |
Impact of Breast Cancer Treatment on Women Especially African American Women |
Amy Yeboah Qwarkume |
Howard University |
PLCO |
Oct 3, 2023 |
PLCO-1343 |
DII/E-DII Scores |
James Hébert |
University of South Carolina |
PLCO |
Oct 3, 2023 |
PLCO-1326 |
Deep Learning Algorithm for Lung Adenocarcinoma Subtype Recognition Based on Multimodal Data |
Ying Ji |
Beijing Chao-Yang Hospital, Capital Medical University |
NLST |
Oct 3, 2023 |
NLST-1133 |
Investigation into the Effect of Dimensionality Reduction Techniques in Machine Learning Algorithms |
Oluwademilade Adeyemo |
University of Hull |
PLCO |
Sep 28, 2023 |
PLCO-1338 |
Precision Diagnosis of Cancers Based on Artificial Intelligence Pathology Analysis |
Biyue Zhu |
Children's Hospital of Chongqing Medical University, China |
PLCO |
Sep 28, 2023 |
PLCOI-1341 |